Brind.

Amylyx Pharmaceuticals previously treated ALS using AMX0035 and gained approval in Canada.

1 report, 1 independent Updated Aug 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amylyx Pharmaceuticals Als

Keep exploring

The entities involved

Amylyx Pharmaceuticals
American biopharmaceutical company
- Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.Sun 06:52
Als
river in Vienna

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 28Pharmaceutical TechnologyAmylyx culls rare neurological disorder programme after trial failure Amylyx Pharmaceuticals has discontinued a clinical programme evaluating a neuronal cell death inhibitor as a result of disappoint